Will MDMA-assisted therapy for PTSD be approved by the FDA before 2030?
26
1kṀ4236
2030
74%
chance
FDA advisory committee recommends denying Lykos's New Drug Application for MDMA-assisted psychotherapy
-5.0%
on
FDA officially rejects Lykos's application

This market resolves to 'YES' if the FDA announces approval of MDMA-assisted therapy for PTSD by January 1st, 2030. If approval is announced prior to market closing, then the market will resolve early.

EDIT: If neither of these conditions are met, then the market will resolve to 'NO'

Get
Ṁ1,000
to start trading!
© Manifold Markets, Inc.TermsPrivacy